Nonprofit · EIN 85-0110669
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Tax-exempt · ALBUQUERQUE, NM 87108
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $83,397,041 | $87,744,696 | -$4,347,655 | $255,478,512 | $48,316,899 | $207,161,613 |
| June 30, 2024 | 990 | $91,209,797 | $91,486,502 | -$276,705 | $256,421,032 | $44,398,188 | $212,022,844 |
| June 30, 2023 | 990 | $112,131,523 | $94,680,185 | $17,451,338 | $259,201,284 | $51,866,764 | $207,334,520 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $12,194,618
- of which government grants
- $9,294,265
- Program service revenue
- $63,041,316
- Investment income
- $5,409,527
- Royalties
- $32,278
- Net rental income
- $284,352
- Net gain from sales of assets
- $3,940,037
- Other revenue
- $2,751,580
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $1,718,514
- Other salaries and wages
- $25,739,405
- Salaries, compensation and benefits (total)
- $38,722,912
- Professional fundraising fees
- $0
- Legal fees
- $29,439
- Accounting fees
- $280,265
- Occupancy
- $3,634,153
- Travel
- $2,184,392
- Depreciation
- $7,600,442
- Program services (functional)
- $77,084,856
- Management and general (functional)
- $10,659,840
Balance sheet and other
- Total assets, start of year
- $256,421,032
- Total assets, end of year
- $255,478,512
- Total liabilities, end of year
- $48,316,899
- Net assets, end of year
- $207,161,613
- Land, buildings and equipment
- $131,781,483
- Publicly traded securities
- $53,251,483
- Net assets without donor restrictions
- $207,161,613
- Gross receipts
- $122,941,955
- Employees
- 495
- Volunteers
- 6
- Year formed
- 1965
- State of legal domicile
- NM
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| ALAN KADISH | PRESIDENT AND CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $0 | $1,265,315 | $121,813 |
| ROBERT W RUBIN PHD | CEO (THROUGH 5/31/25) Officer | 38 | $782,222 | $0 | $63,292 |
| SHANNON L TOMA | EXEC VP, COO, CFO Officer | 40 | $705,999 | $0 | $64,070 |
| SALOMON AMAR | CEO (STARTING 6/1/25) Officer | 38 | $0 | $641,578 | $71,238 |
| STEVEN A BELINSKY | VP, ACADEMIC RESEARCH/SR SCIENTIST Highest-paid employee | 40 | $395,524 | $0 | $40,460 |
| NICHOLAS S JANIGA | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $355,397 | $71,226 |
| MATTHEW F BONILLA | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $333,033 | $47,831 |
| KENT KIEHL | EXECUTIVE SCIENCE OFFICER Highest-paid employee | 40 | $334,368 | $0 | $41,570 |
| MELANIE DOYLE-EISELE | SR. DIRECTOR OF LIFE SCIENCES Highest-paid employee | 40 | $295,478 | $0 | $38,944 |
| PHILLIP KUEHL | SR. DIR., PRECLINICAL DRUG DEVELOPMENT Highest-paid employee | 40 | $296,621 | $0 | $32,016 |
| DAVID M FLANDERS | VP, HUMAN RESOURCES Highest-paid employee | 40 | $289,027 | $0 | $34,754 |
| CHARLES MATTIELLO | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $233,171 | $25,447 |
| JANE DELGADO | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| WANDA HERNANDEZ | SPECIAL APPOINTEE (THRU 9/23/24) Trustee or director | 2 | $0 | $0 | $0 |
| JACKIE LOVELACE JOHNSON | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
4 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| JOSPEH D MARK | DIRECTOR Trustee or director | 2 | $0 |
| LAWRENCE D PLATT | DIRECTOR Trustee or director | 2 | $0 |
| MARGARET RETTER | DIRECTOR Trustee or director | 2 | $0 |
| ZVIGMOND RYZMAN | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended June 30, 2024: 18 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| ALAN KADISH | PRESIDENT AND CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $0 | $1,049,960 | $119,250 |
| ROBERT W RUBIN PHD | CEO, ADVISORY NON-VOTING DIRECTOR Officer | 38 | $874,428 | $0 | $67,507 |
| SHANNON L TOMA | TREASURER, EXEC VP, COO, CFO Officer | 40 | $713,675 | $0 | $47,523 |
| STEVEN A BELINSKY | VP ACADEMIC RESEARCH/SR SCIENTIST Highest-paid employee | 40 | $404,462 | $0 | $46,729 |
| KENT KIEHL | EXECUTIVE SCIENCE OFFICER Highest-paid employee | 40 | $386,988 | $0 | $43,066 |
| NICHOLAS S JANIGA | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $345,982 | $78,777 |
| DAVID M FLANDERS | VP, HUMAN RESOURCES Highest-paid employee | 40 | $314,924 | $0 | $38,681 |
| MATTHEW F BONILLA | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $300,777 | $44,352 |
| JACOB D MCDONALD | VP APPLIED SCIENCE (THRU 9/7/2023) Key employee | 40 | $287,941 | $0 | $40,876 |
| ANDREW R MAYER | VP OF INTERDISCIPLINARY SCIENCE Highest-paid employee | 40 | $282,904 | $0 | $41,391 |
| EDWARD G BARRETT | SR. DIRECTOR OF PHARMACOLOGY Highest-paid employee | 40 | $268,562 | $0 | $44,658 |
| WANDA HERNANDEZ | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $195,253 | $31,605 |
| JANE DELGADO | DIR. VICE CHAIR NOM COMMITTEE Trustee or director | 2 | $0 | $0 | $0 |
| JACKIE LOVELACE JOHNSON | CHAIRWOMAN OF THE BOARD, DIRECTORS Trustee or director | 2 | $0 | $0 | $0 |
| JOSPEH D MARK | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| LAWRENCE D PLATT | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| MARGARET RETTER | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| ZVIGMOND RYZMAN | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
990 for the year ended June 30, 2023: 29 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| ALAN KADISH PRESIDENT | AND CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $37,907 | $1,044,121 | $227,585 |
| ROBERT RUBIN PHD | CEO, ADVISORY NON-VOTING DIRECTOR Officer | 39.5 | $850,098 | $0 | $104,504 |
| SHANNON TOMA | EXEC VP, COO/CFO Officer | 39.5 | $666,454 | $0 | $40,295 |
| STEVEN BELINSKY VP ACADEMIC | RESEARCH / SR. SCIENTIST Highest-paid employee | 40 | $397,874 | $0 | $40,921 |
| JACOB MCDONALD | VP, APPLIED SCIENCE Key employee | 40 | $355,090 | $0 | $43,582 |
| KENT KIEHL | EXECUTIVE SCIENCE OFFICER Highest-paid employee | 40 | $357,680 | $0 | $40,416 |
| DAVID FLANDERS | VP, HUMAN RESOURCES Highest-paid employee | 40 | $286,667 | $0 | $34,159 |
| ANDREW MAYER | VP, INTERDISCIPLINARY SCIE Highest-paid employee | 40 | $250,931 | $0 | $39,232 |
| EDWARD BARRETT | SR. DIRECTOR, PHARMACOLOGY Highest-paid employee | 40 | $247,479 | $0 | $38,800 |
| JACKIE LOVELACE JOHNSON | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| JANE DELGADO | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| CHRIS SPENCER CPA DIR | CHAIR BUDGET & FINANCE(THRU 7/5/22) Trustee or director, Officer | 2 | $0 | $0 | $0 |
| PAMELA SULLIVAN DIR CHAIR | AUDIT & COMPENSATION (THRU 7/5/22) Trustee or director, Officer | 2 | $0 | $0 | $0 |
| MATTHEW F BONILLA | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $0 | $0 |
| J GRANT BURCHAM | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| TESS BURLESON | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| SANDRA CHAVEZ | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| MAJOR GENERAL JOHN DOESBURG | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| GREGORY DOWNEY MD | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| TERRY DUNLAY | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| SARA EASTERSON-BOND | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| WANDA HERNANDEZ | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $0 | $0 |
| JOSEPH D MARK | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| NICHOLAS S JANIGA | SPECIAL APPOINTEE Trustee or director | 2 | $0 | $0 | $0 |
| LAWRENCE D PLATT | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| MARGARET RETTER | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| ZVIGMOND RYZMAN | DIRECTOR Trustee or director | 2 | $0 | $0 | $0 |
| MELVIN TWIEST MD | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
| RICHARD GILL PHD | DIRECTOR (THRU 7/5/22) Trustee or director | 2 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 2425 RIDGECREST DR SE, ALBUQUERQUE, NM 87108-5129
- Principal officer (990 for 2024)
- SALOMON AMAR, 2425 RIDGECREST DRIVE SE, ALBUQUERQUE, NM 87108
- Signed the 990
- SHANNON L TOMA, EXEC VP, COO, CFO
- Phone
- (505) 348-9361
- Website
- WWW.LOVELACEBIOMEDICAL.ORG
- Return prepared by
- BAKER TILLY ADVISORY GROUP LP
Mission
THE LOVELACE BIOMEDICAL RESEARCH INSTITUTE (LBRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF DISEASES. LBRI IS DEDICATED TO THE DISCOVERY AND ADVANCEMENT OF CLINICAL SOLUTIONS FOR PREVENTION, DIAGNOSIS, TREATMENT AND CURING DISEASES THROUGH RESEARCH. THE RESEARCH IS AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY, NEUROLOGICAL AND OTHER HEALTH HAZARDS; MENTAL ILLNESS; TRAUMATIC BRAIN INJURY AND OTHER BRAIN DISORDERS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LBRI IS BASED IN ALBUQUERQUE, NEW MEXICO.
Program accomplishments
- MEDICAL RESEARCH AND EDUCATIONAL ACTIVITY IN THE AREAS OF BASIC BIOMEDICAL RESEARCH, HEALTH AND POPULATION STUDIES, INCLUDING RESPIRATORY DISEASES SUCH AS ASTHMA, COPD, ALLERGY AND TOXIC EFFECTS OF ENVIRONMENTAL FACTORS. ADDITIONAL AREAS INCLUDE NEUROLOGIC CONDITIONS SUCH AS TRAUMATIC BRAIN INJURY, ADDICTION AND PSYCHOPATHY.Expenses $77,084,856 · revenue $63,041,316
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 85-0110669
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1969
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H920)
- Assets (IRS master file)
- $255,478,512
- Income (IRS master file)
- $122,941,955
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $83,397,041 | $87,744,696 | $255,478,512 | IRS |
| 990 | June 2024 | $91,209,797 | $91,486,502 | $256,421,032 | IRS |
| 990 | June 2023 | $112,131,523 | $94,680,185 | $259,201,284 | XML |
| 990 | June 2022 | $71,507,956 | $66,188,457 | $184,740,544 | IRS |
| 990-T | June 2022 | – | – | – | IRS |
| 990 | September 2021 | – | – | – | IRS |
| 990-T | September 2021 | – | – | – | IRS |
| 990 | September 2020 | – | – | – | IRS |
| 990 | September 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 85-0110669).
Questions about LOVELACE BIOMEDICAL RESEARCH INSTITUTE
- What is the EIN of LOVELACE BIOMEDICAL RESEARCH INSTITUTE?
- The employer identification number (EIN) of LOVELACE BIOMEDICAL RESEARCH INSTITUTE is 85-0110669.
- Is LOVELACE BIOMEDICAL RESEARCH INSTITUTE tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1969.
- Are donations to LOVELACE BIOMEDICAL RESEARCH INSTITUTE tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does LOVELACE BIOMEDICAL RESEARCH INSTITUTE file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of LOVELACE BIOMEDICAL RESEARCH INSTITUTE due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did LOVELACE BIOMEDICAL RESEARCH INSTITUTE last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of LOVELACE BIOMEDICAL RESEARCH INSTITUTE?
- The 990 for the year ended June 30, 2025 names SALOMON AMAR.
- Who are the officers and directors of LOVELACE BIOMEDICAL RESEARCH INSTITUTE?
- The 990 for the year ended June 30, 2025 lists 19 people; 7 received compensation from the organization.
- How much revenue does LOVELACE BIOMEDICAL RESEARCH INSTITUTE have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $83,397,041, expenses of $87,744,696 and total assets of $255,478,512 at year end.
Other nonprofits in ALBUQUERQUE
- BIOMEDICAL RESEARCH INSTITUTE OF NEW MEXICO EIN 85-0374063 · last filed 990 for 2025
- NEW MEXICO CANCER CARE ALLIANCE EIN 02-0624051 · last filed 990 for 2025
- SOCIETY FOR MELANOMA RESEARCH LTD EIN 81-0638484 · last filed 990 for 2024
- CANCER SERVICES OF NEW MEXICO FOUNDATION EIN 20-3688671 · last filed 990 for 2025
- CANCER SERVICES OF NEW MEXICO EIN 85-0481885 · last filed 990 for 2025
- NEW MEXICO HEALTH ENHANCEMENT AND MARATHON CLINICS RESEARCH FOUNDAT EIN 85-0411502 · last filed 990-N for 2024
- EPILEPSY RESEARCH ASSOCIATION EIN 47-5385473 · last filed 990-N for 2025
- SIERRA RAYN CHILDRENS NEUROBLASTOMA FOUNDATION INC EIN 27-4517683 · last filed 990-N for 2025
All nonprofits in ALBUQUERQUE · New Mexico · Medical research